Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1260853.RA653klp7yGE7ELQ3I4EO5f-1ngbUIYICk-VX6Utf4IMw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1260853.RA653klp7yGE7ELQ3I4EO5f-1ngbUIYICk-VX6Utf4IMw130_assertion type Assertion NP1260853.RA653klp7yGE7ELQ3I4EO5f-1ngbUIYICk-VX6Utf4IMw130_head.
- NP1260853.RA653klp7yGE7ELQ3I4EO5f-1ngbUIYICk-VX6Utf4IMw130_assertion description "[In this study, we evaluated a role for the HDMX-S/FL ratio as one such biomarker, based on its association with other suppressor mutations that confer worse prognosis in sarcomas, another type of cancer that is surveilled by p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260853.RA653klp7yGE7ELQ3I4EO5f-1ngbUIYICk-VX6Utf4IMw130_provenance.
- NP1260853.RA653klp7yGE7ELQ3I4EO5f-1ngbUIYICk-VX6Utf4IMw130_assertion evidence source_evidence_literature NP1260853.RA653klp7yGE7ELQ3I4EO5f-1ngbUIYICk-VX6Utf4IMw130_provenance.
- NP1260853.RA653klp7yGE7ELQ3I4EO5f-1ngbUIYICk-VX6Utf4IMw130_assertion SIO_000772 25649770 NP1260853.RA653klp7yGE7ELQ3I4EO5f-1ngbUIYICk-VX6Utf4IMw130_provenance.
- NP1260853.RA653klp7yGE7ELQ3I4EO5f-1ngbUIYICk-VX6Utf4IMw130_assertion wasDerivedFrom befree-2016 NP1260853.RA653klp7yGE7ELQ3I4EO5f-1ngbUIYICk-VX6Utf4IMw130_provenance.
- NP1260853.RA653klp7yGE7ELQ3I4EO5f-1ngbUIYICk-VX6Utf4IMw130_assertion wasGeneratedBy ECO_0000203 NP1260853.RA653klp7yGE7ELQ3I4EO5f-1ngbUIYICk-VX6Utf4IMw130_provenance.